The Food and Drug Administration is reversing course on its requirement for all staffers to report to the office.

Commissioner Ricardo Lara said Department of Insurance employees have “risen to the occasion” while working remotely.

An internal email obtained by The Associated Press states that FDA leadership are “allowing review staff and supervisors to resume telework” at least two days a week. The policy shift was ...